Helios - Multi-Channel Potentiostat

A potentiostat is the electronic hardware required to control a three electrode cell and is used to run most electroanalytical experiments. In electroanalytical experiments, it is often used to read the signal from sensor chips with an analyte.

This equipment is fundamental to modern electrochemical studies using voltammetry for investigations of reaction mechanisms related to redox chemistry and other chemical phenomena.

Helios

Multi-Channel Potentiostat

Helios is the first truly affordable multi-channel electrochemical workstation that has 16 independent channels, all with independently addressable control. Its channel configuration is easy to use and efficient – capable of performing up to 16 different electrochemical experiments at the same time.

The Helios, as well as our electrochemical sensor chips, is a great representation of our novel sensor technology that is unlike the conventional electrochemical sensor chip and potentiostat combination. Using our universal technology platform, experiments such as electrolyte assays, genetic assays, and immunoassays are able to be performed using raw samples - no PCR required; yielding precise, quantitative results in under an hour.

By adapting the advanced USB connection, Helios is sleek and compact in design like no other of its kind; providing you with the utmost performance – through the use of just one cable.

Helios Applications – Electroanalysis

Electrochemical research is a broad research field and directly contributes to a wide variety of applications in the medical field. GeneFluidics’ Helios currently focuses and contributes in the fields of pathogen identification, antimicrobial susceptibility testing (AST), and cancer biomarker screening.

In all fields of diagnostics, accuracy, reliability, and speed are very essential factors. In answer to that, GeneFluidics develops highly sensitive and efficient detection platforms and point-of-care research systems to deliver prompt, precise results for research in medicine and other life sciences. GeneFluidics is working to develop and optimize products that will be more reliable and easy-to-use in hospital and clinical settings. Pursuant to that goal, we have been in close collaboration with physicians in urology, pediatric pathology, and oral oncology.

As a case in point, typical microbial analysis of bacterial infections relies on a culturing process requiring one to three days before results are available. This often forces clinicians to prescribe antibiotics before test results are available. Driven by this heedless prescription of antibiotics, emergence of drug-resistant pathogens has been a growing threat to global health.

With the GeneFluidics’ detection technology, rapid antimicrobial susceptibility testing (AST) is possible. We are capable of cutting the required days it takes to provide susceptibility data to a matter of just hours. This revolutionary platform could enable clinicians to treat patients based on accurate pathogen identification and resistance information without promoting the growth of drug-resistant pathogens.